{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T07:04:09Z","timestamp":1774767849372,"version":"3.50.1"},"reference-count":125,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Chest Medicine"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.ccm.2013.08.013","type":"journal-article","created":{"date-parts":[[2013,10,9]],"date-time":"2013-10-09T09:47:45Z","timestamp":1381312065000},"page":"799-810","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Standard Nonspecific Therapies in the Management of Pulmonary Arterial Hypertension"],"prefix":"10.1016","volume":"34","author":[{"given":"Maor","family":"Sauler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wassim H.","family":"Fares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terence K.","family":"Trow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ccm.2013.08.013_bib1","doi-asserted-by":"crossref","first-page":"343","DOI":"10.7326\/0003-4819-115-5-343","article-title":"Survival in patients with primary pulmonary hypertension. Results from a national prospective registry","volume":"115","author":"D'Alonzo","year":"1991","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.ccm.2013.08.013_bib2","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1378\/chest.06-2674","article-title":"Medical therapy for pulmonary arterial hypertension: updated ACCP evidence-based clinical\u00a0practice guidelines","volume":"131","author":"Badesch","year":"2007","journal-title":"Chest"},{"issue":"17","key":"10.1016\/j.ccm.2013.08.013_bib3","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.jacc.2009.01.004","volume":"53","author":"McLaughlin","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.ccm.2013.08.013_bib4","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ccm.2006.12.003","article-title":"Standard therapies for pulmonary arterial hypertension","volume":"28","author":"Alam","year":"2007","journal-title":"Clin Chest Med"},{"issue":"4","key":"10.1016\/j.ccm.2013.08.013_bib5","doi-asserted-by":"crossref","first-page":"L683","DOI":"10.1152\/ajplung.2000.279.4.L683","article-title":"Hypoxic vasoconstriction in intact lungs: a role for NADPH oxidase-derived H2O2?","volume":"279","author":"Weissmann","year":"2000","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"3","key":"10.1016\/j.ccm.2013.08.013_bib6","doi-asserted-by":"crossref","first-page":"391","DOI":"10.7326\/0003-4819-93-3-391","article-title":"Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Nocturnal Oxygen Therapy Trial Group","volume":"93","year":"1980","journal-title":"Ann Intern Med"},{"issue":"8222","key":"10.1016\/j.ccm.2013.08.013_bib7","first-page":"681","article-title":"Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Report of the Medical Research Council Working Party","volume":"1","year":"1981","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ccm.2013.08.013_bib8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.7326\/0003-4819-102-1-29","article-title":"Hemodynamic response to oxygen therapy in chronic obstructive pulmonary disease","volume":"102","author":"Timms","year":"1985","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.1016\/j.ccm.2013.08.013_bib9","first-page":"798","article-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summary","volume":"46","author":"Pauwels","year":"2001","journal-title":"Respir Care"},{"issue":"19","key":"10.1016\/j.ccm.2013.08.013_bib10","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1056\/NEJM198405103101903","article-title":"The diffusing capacity as a predictor of arterial oxygen desaturation during exercise in patients with chronic obstructive pulmonary disease","volume":"310","author":"Owens","year":"1984","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.ccm.2013.08.013_bib11","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/0002-9343(86)90620-0","article-title":"Resting single-breath diffusing capacity as a screening test for exercise-induced hypoxemia","volume":"80","author":"Kelley","year":"1986","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.ccm.2013.08.013_bib12","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1378\/chest.06-1378","article-title":"Predictors of nocturnal oxygen desaturation in pulmonary arterial hypertension","volume":"131","author":"Minai","year":"2007","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.ccm.2013.08.013_bib13","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1136\/hrt.55.4.385","article-title":"Effect of long term oxygen treatment at home in children with pulmonary vascular disease","volume":"55","author":"Bowyer","year":"1986","journal-title":"Br Heart J"},{"issue":"1","key":"10.1016\/j.ccm.2013.08.013_bib14","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1183\/09031936.03.00088302","article-title":"Pulmonary arterial hypertension in children","volume":"21","author":"Widlitz","year":"2003","journal-title":"Eur Respir J"},{"issue":"9","key":"10.1016\/j.ccm.2013.08.013_bib15","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1164\/ajrccm.164.9.2106076","article-title":"Nocturnal oxygen therapy in patients with the Eisenmenger syndrome","volume":"164","author":"Sandoval","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"issue":"Suppl 1","key":"10.1016\/j.ccm.2013.08.013_bib16","doi-asserted-by":"crossref","first-page":"72S","DOI":"10.1378\/chest.126.1_suppl.72S","article-title":"Pulmonary artery hypertension and sleep-disordered breathing: ACCP evidence-based clinical practice guidelines","volume":"126","author":"Atwood","year":"2004","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.ccm.2013.08.013_bib17","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/0002-9343(75)90502-1","article-title":"Arterial blood gases and pH during sleep in chronic obstructive pulmonary disease","volume":"58","author":"Koo","year":"1975","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.ccm.2013.08.013_bib18","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/BF01732637","article-title":"Sleep apnea and pulmonary hypertension","volume":"64","author":"Podszus","year":"1986","journal-title":"Klin Wochenschr"},{"issue":"6","key":"10.1016\/j.ccm.2013.08.013_bib19","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1159\/000050574","article-title":"Daytime pulmonary hypertension in patients with obstructive sleep apnea: the effect of continuous positive airway pressure on pulmonary hemodynamics","volume":"68","author":"Alchanatis","year":"2001","journal-title":"Respiration"},{"issue":"2","key":"10.1016\/j.ccm.2013.08.013_bib20","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1164\/ajrccm.165.2.2010092","article-title":"Continuous positive airway pressure treatment improves pulmonary hemodynamics in patients with obstructive sleep apnea","volume":"165","author":"Sajkov","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"10.1016\/j.ccm.2013.08.013_bib21","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1093\/eurheartj\/ehi807","article-title":"Pulmonary hypertension in obstructive sleep apnoea: effects of continuous positive airway pressure: a randomized, controlled cross-over study","volume":"27","author":"Arias","year":"2006","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.ccm.2013.08.013_bib22","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1378\/chest.120.2.369","article-title":"The obesity-hypoventilation syndrome revisited: a prospective study of 34 consecutive cases","volume":"120","author":"Kessler","year":"2001","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.ccm.2013.08.013_bib23","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.ccm.2009.05.004","article-title":"The pickwickian syndrome-obesity hypoventilation syndrome","volume":"30","author":"Littleton","year":"2009","journal-title":"Clin Chest Med"},{"issue":"4","key":"10.1016\/j.ccm.2013.08.013_bib24","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1378\/chest.119.4.1102","article-title":"The obesity hypoventilation syndrome can be treated with noninvasive mechanical ventilation","volume":"119","author":"Masa","year":"2001","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.ccm.2013.08.013_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.amjmed.2003.08.022","article-title":"Obesity-associated hypoventilation in hospitalized patients: prevalence, effects, and outcome","volume":"116","author":"Nowbar","year":"2004","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.ccm.2013.08.013_bib26","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1365-2796.2007.01765.x","article-title":"Mortality and prognostic factors in patients with obesity-hypoventilation syndrome undergoing noninvasive ventilation","volume":"261","author":"Budweiser","year":"2007","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.ccm.2013.08.013_bib27","unstructured":"Chronic Heart Failure: National Clinical Guideline for Diagnosis and Management in Primary and Secondary Care: Partial Update. London 2010."},{"issue":"4","key":"10.1016\/j.ccm.2013.08.013_bib28","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1161\/01.CIR.80.4.823","article-title":"Early improvement in left ventricular diastolic function after relief of chronic right ventricular pressure overload","volume":"80","author":"Dittrich","year":"1989","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ccm.2013.08.013_bib29","doi-asserted-by":"crossref","first-page":"H1528","DOI":"10.1152\/ajpheart.01031.2005","article-title":"Impaired left ventricular filling due to right-to-left ventricular interaction in patients with pulmonary arterial hypertension","volume":"290","author":"Gan","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"7","key":"10.1016\/j.ccm.2013.08.013_bib30","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/0002-9149(78)90872-X","article-title":"Left ventricular function in chronic pulmonary hypertension","volume":"41","author":"Krayenbuehl","year":"1978","journal-title":"Am J Cardiol"},{"issue":"10","key":"10.1016\/j.ccm.2013.08.013_bib31","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N\u00a0Engl J Med"},{"issue":"4 Pt 1","key":"10.1016\/j.ccm.2013.08.013_bib32","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1164\/ajrccm.157.4.9704106","article-title":"Amiloride analogs inhibit chronic hypoxic pulmonary hypertension","volume":"157","author":"Quinn","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.ccm.2013.08.013_bib33","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.amjcard.2004.09.006","article-title":"New predictors of outcome in idiopathic pulmonary arterial hypertension","volume":"95","author":"Kawut","year":"2005","journal-title":"Am J Cardiol"},{"issue":"7772","key":"10.1016\/j.ccm.2013.08.013_bib34","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0140-6736(72)92956-X","article-title":"Resurgence of epidemic dropsy in India","volume":"2","author":"Krishnamachari","year":"1972","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ccm.2013.08.013_bib35","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1053\/pcad.2002.31591","article-title":"Digoxin","volume":"44","author":"Eichhorn","year":"2002","journal-title":"Prog Cardiovasc Dis"},{"issue":"2","key":"10.1016\/j.ccm.2013.08.013_bib36","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0025-7125(02)00172-4","article-title":"Digoxin remains useful in the management of chronic heart failure","volume":"87","author":"Dec","year":"2003","journal-title":"Med Clin North Am"},{"issue":"3","key":"10.1016\/j.ccm.2013.08.013_bib37","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1172\/JCI113113","article-title":"Comparison of effects of dobutamine and ouabain on left ventricular contraction and relaxation in closed-chest dogs","volume":"80","author":"Little","year":"1987","journal-title":"J\u00a0Clin Invest"},{"issue":"12","key":"10.1016\/j.ccm.2013.08.013_bib38","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1161\/01.CIR.94.12.3155","article-title":"Influence of isoproterenol and ouabain on excitation-contraction coupling, cross-bridge function, and energetics in failing human myocardium","volume":"94","author":"Hasenfuss","year":"1996","journal-title":"Circulation"},{"issue":"5\u00a0Suppl A","key":"10.1016\/j.ccm.2013.08.013_bib39","doi-asserted-by":"crossref","first-page":"51A","DOI":"10.1016\/S0735-1097(85)80463-0","article-title":"Effects of digitalis on the normal and\u00a0the failing heart","volume":"5","author":"Braunwald","year":"1985","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.ccm.2013.08.013_bib40","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1172\/JCI104796","article-title":"Studies on digitalis. IX. Effects of ouabain on the nonfailing human heart","volume":"42","author":"Mason","year":"1963","journal-title":"J\u00a0Clin Invest"},{"issue":"4","key":"10.1016\/j.ccm.2013.08.013_bib41","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1001\/jama.1988.03720040031022","article-title":"Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure. The Captopril-Digoxin Multicenter Research Group","volume":"259","year":"1988","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ccm.2013.08.013_bib42","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/0735-1097(89)90561-5","article-title":"Comparative hemodynamic and neurohormonal effects of intravenous captopril and digoxin and their combinations in patients with severe heart failure","volume":"13","author":"Gheorghiade","year":"1989","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.ccm.2013.08.013_bib43","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/0735-1097(91)90491-Q","article-title":"Enalapril versus digoxin in patients with congestive heart failure: a multicenter study. Canadian Enalapril Versus Digoxin Study Group","volume":"18","author":"Davies","year":"1991","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.ccm.2013.08.013_bib44","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1161\/01.CIR.80.1.65","article-title":"Sympathoinhibitory responses to digitalis glycosides in heart failure patients. Direct evidence from sympathetic neural recordings","volume":"80","author":"Ferguson","year":"1989","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ccm.2013.08.013_bib45","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0735-1097(96)00120-9","article-title":"Digoxin reduces cardiac sympathetic activity in severe congestive heart failure","volume":"28","author":"Newton","year":"1996","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.ccm.2013.08.013_bib46","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/0735-1097(93)90579-P","article-title":"Double-blind placebo-controlled study of ibopamine and digoxin in patients with mild to moderate heart failure: results of the Dutch Ibopamine Multicenter Trial (DIMT)","volume":"22","author":"van Veldhuisen","year":"1993","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.ccm.2013.08.013_bib47","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1161\/01.CIR.84.5.2181","article-title":"Digoxin. A neurohormonal modulator in heart failure?","volume":"84","author":"Gheorghiade","year":"1991","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ccm.2013.08.013_bib48","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0735-1097(94)00417-O","article-title":"Effect of\u00a0long-term digoxin therapy on autonomic function in patients with chronic heart failure","volume":"25","author":"Krum","year":"1995","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.ccm.2013.08.013_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199307013290101","article-title":"Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study","volume":"329","author":"Packer","year":"1993","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.ccm.2013.08.013_bib50","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1056\/NEJM198903163201101","article-title":"A\u00a0comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure","volume":"320","author":"DiBianco","year":"1989","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.ccm.2013.08.013_bib51","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/0735-1097(93)90403-N","article-title":"Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. PROVED Investigative Group","volume":"22","author":"Uretsky","year":"1993","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"18","key":"10.1016\/j.ccm.2013.08.013_bib52","doi-asserted-by":"crossref","first-page":"48G","DOI":"10.1016\/0002-9149(92)91254-2","article-title":"Review of randomized trials of digoxin therapy in patients with chronic heart failure","volume":"69","author":"Gheorghiade","year":"1992","journal-title":"Am J Cardiol"},{"issue":"8","key":"10.1016\/j.ccm.2013.08.013_bib53","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1056\/NEJM199702203360801","article-title":"The effect of digoxin on mortality and morbidity in patients with heart failure. The Digitalis Investigation Group","volume":"336","year":"1997","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.ccm.2013.08.013_bib54","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1378\/chest.114.3.787","article-title":"The short-term effects of digoxin in patients with right ventricular dysfunction from pulmonary hypertension","volume":"114","author":"Rich","year":"1998","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.ccm.2013.08.013_bib55","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1073\/pnas.1120385109","article-title":"Digoxin inhibits development of hypoxic pulmonary hypertension in mice","volume":"109","author":"Abud","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.ccm.2013.08.013_bib56","doi-asserted-by":"crossref","first-page":"283","DOI":"10.7326\/0003-4819-95-3-283","article-title":"Effect of digoxin on right ventricular function in severe chronic airflow obstruction. A controlled clinical trial","volume":"95","author":"Mathur","year":"1981","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.ccm.2013.08.013_bib57","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0002-9343(98)00195-8","article-title":"A\u00a0case series of hospitalized patients with elevated digoxin levels","volume":"105","author":"Marik","year":"1998","journal-title":"Am J Med"},{"issue":"5","key":"10.1016\/j.ccm.2013.08.013_bib58","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/BF00878556","article-title":"Digoxin and increased mortality among patients recovering from acute myocardial infarction: importance of digoxin dose. The SPRINT Study Group","volume":"9","author":"Leor","year":"1995","journal-title":"Cardiovasc Drugs Ther"},{"issue":"7","key":"10.1016\/j.ccm.2013.08.013_bib59","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1001\/jama.289.7.871","article-title":"Association of serum digoxin concentration and outcomes in patients with heart failure","volume":"289","author":"Rathore","year":"2003","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.ccm.2013.08.013_bib60","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/0033-0620(84)90012-4","article-title":"Digitalis glycosides: mechanisms and manifestations of toxicity. Part I","volume":"26","author":"Smith","year":"1984","journal-title":"Prog Cardiovasc Dis"},{"issue":"1","key":"10.1016\/j.ccm.2013.08.013_bib61","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0002-9343(74)90769-4","article-title":"A\u00a0nomogram for digoxin therapy","volume":"57","author":"Jelliffe","year":"1974","journal-title":"Am J Med"},{"issue":"13","key":"10.1016\/j.ccm.2013.08.013_bib62","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1001\/jama.289.13.1652","article-title":"Drug-drug interactions among elderly patients hospitalized for drug toxicity","volume":"289","author":"Juurlink","year":"2003","journal-title":"JAMA"},{"issue":"12 Suppl S","key":"10.1016\/j.ccm.2013.08.013_bib63","doi-asserted-by":"crossref","first-page":"13S","DOI":"10.1016\/j.jacc.2004.02.029","article-title":"Cellular and molecular pathobiology of pulmonary arterial hypertension","volume":"43","author":"Humbert","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.ccm.2013.08.013_bib64","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0012-3692(15)51873-4","article-title":"Thrombotic arteriopathy and anticoagulation in pulmonary hypertension","volume":"130","author":"Johnson","year":"2006","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.ccm.2013.08.013_bib65","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1378\/chest.77.5.614","article-title":"Lung biopsy specimens in the evaluation of pulmonary vascular disease","volume":"77","author":"Wagenvoort","year":"1980","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.ccm.2013.08.013_bib66","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0025-6196(12)65277-X","article-title":"Primary pulmonary hypertension: a histopathologic study of 80 cases","volume":"60","author":"Bjornsson","year":"1985","journal-title":"Mayo Clin Proc"},{"issue":"5","key":"10.1016\/j.ccm.2013.08.013_bib67","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1161\/01.CIR.80.5.1198","article-title":"Histopathology of primary pulmonary hypertension. A qualitative and quantitative study of pulmonary blood vessels from 58 patients in the National Heart, Lung, and Blood Institute, Primary Pulmonary Hypertension Registry","volume":"80","author":"Pietra","year":"1989","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ccm.2013.08.013_bib68","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1056\/NEJM199207093270202","article-title":"An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension","volume":"327","author":"Christman","year":"1992","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.ccm.2013.08.013_bib69","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1378\/chest.110.3.710","article-title":"Coagulation and fibrinolytic profiles in patients with severe pulmonary hypertension","volume":"110","author":"Welsh","year":"1996","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.ccm.2013.08.013_bib70","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/BF01747854","article-title":"Characterization of von Willebrand factor in primary pulmonary hypertension","volume":"14","author":"Collados","year":"1999","journal-title":"Heart Vessels"},{"issue":"5","key":"10.1016\/j.ccm.2013.08.013_bib71","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1378\/chest.114.5.1276","article-title":"Circulating von Willebrand factor antigen as a predictor of short-term prognosis in pulmonary hypertension","volume":"114","author":"Lopes","year":"1998","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.ccm.2013.08.013_bib72","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1177\/000331979304400905","article-title":"Circulating platelet aggregates indicative of in\u00a0vivo platelet activation in pulmonary hypertension","volume":"44","author":"Lopes","year":"1993","journal-title":"Angiology"},{"issue":"2","key":"10.1016\/j.ccm.2013.08.013_bib73","first-page":"294","article-title":"von Willebrand factor abnormalities in primary pulmonary hypertension","volume":"135","author":"Geggel","year":"1987","journal-title":"Am Rev Respir Dis"},{"issue":"4","key":"10.1016\/j.ccm.2013.08.013_bib74","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1164\/ajrccm.150.4.7921465","article-title":"Fibrinogen, t-PA, and PAI-1 plasma levels in patients with pulmonary hypertension","volume":"150","author":"Huber","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.ccm.2013.08.013_bib75","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1378\/chest.104.5.1455","article-title":"Abnormal multimeric and oligomeric composition is associated with enhanced endothelial expression of von Willebrand factor in pulmonary hypertension","volume":"104","author":"Lopes","year":"1993","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.ccm.2013.08.013_bib76","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S0002-9343(96)80070-2","article-title":"Plasma levels of thrombomodulin in pulmonary hypertension","volume":"101","author":"Cacoub","year":"1996","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.ccm.2013.08.013_bib77","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1161\/01.CIR.82.3.841","article-title":"Fibrinopeptide A levels indicative of pulmonary vascular thrombosis in patients with primary pulmonary hypertension","volume":"82","author":"Eisenberg","year":"1990","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ccm.2013.08.013_bib78","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.thromres.2010.06.020","article-title":"Enhanced hemostatic indices in patients with pulmonary arterial hypertension: an observational study","volume":"126","author":"Can","year":"2010","journal-title":"Thromb Res"},{"issue":"1","key":"10.1016\/j.ccm.2013.08.013_bib79","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0002-9343(90)90111-P","article-title":"Primary pulmonary hypertension in a patient with a familial platelet storage pool disease: role of serotonin","volume":"89","author":"Herve","year":"1990","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.ccm.2013.08.013_bib80","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0002-9343(99)80156-9","article-title":"Increased plasma serotonin in primary pulmonary hypertension","volume":"99","author":"Herve","year":"1995","journal-title":"Am J Med"},{"issue":"10","key":"10.1016\/j.ccm.2013.08.013_bib81","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1161\/01.ATV.20.10.2233","article-title":"High plasma serotonin levels in primary pulmonary hypertension. Effect of long-term epoprostenol (prostacyclin) therapy","volume":"20","author":"Kereveur","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"10.1016\/j.ccm.2013.08.013_bib82","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/0049-3848(85)90295-6","article-title":"Decreased half-life of fibrinogen in primary pulmonary hypertension","volume":"40","author":"Langleben","year":"1985","journal-title":"Thromb Res"},{"issue":"4","key":"10.1016\/j.ccm.2013.08.013_bib83","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1056\/NEJM199507273330403","article-title":"Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension","volume":"333","author":"Giaid","year":"1995","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.ccm.2013.08.013_bib84","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1164\/ajrccm.158.4.9802113","article-title":"Nitric oxide deficiency in fenfluramine- and dexfenfluramine-induced pulmonary hypertension","volume":"158","author":"Archer","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.ccm.2013.08.013_bib85","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1183\/09031936.98.12061446","article-title":"Plasma coagulation profiles in patients with severe primary pulmonary hypertension","volume":"12","author":"Hoeper","year":"1998","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.ccm.2013.08.013_bib86","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1034\/j.1399-3003.2000.15b28.x","article-title":"Thrombotic risk factors in pulmonary hypertension","volume":"15","author":"Wolf","year":"2000","journal-title":"Eur Respir J"},{"issue":"14","key":"10.1016\/j.ccm.2013.08.013_bib87","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/0002-9149(93)90868-D","article-title":"Renal, hemodynamic and neurohormonal effects of atrial natriuretic factor in cardiac allograft recipients treated with cyclosporin A","volume":"72","author":"Lang","year":"1993","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.ccm.2013.08.013_bib88","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1183\/09031936.96.09020356","article-title":"The role of thrombosis in severe pulmonary hypertension","volume":"9","author":"Chaouat","year":"1996","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.ccm.2013.08.013_bib89","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1055\/s-0038-1653857","article-title":"Continuous infusion of prostacyclin decreases plasma levels of t-PA and PAI-1 in primary pulmonary hypertension","volume":"73","author":"Boyer-Neumann","year":"1995","journal-title":"Thromb Haemost"},{"issue":"20","key":"10.1016\/j.ccm.2013.08.013_bib90","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1161\/01.CIR.102.20.2460","article-title":"Improvement of von Willebrand factor proteolysis after prostacyclin infusion in severe pulmonary arterial hypertension","volume":"102","author":"Veyradier","year":"2000","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ccm.2013.08.013_bib91","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1164\/rccm.200412-1684OC","article-title":"Decreased exhaled nitric oxide in pulmonary arterial hypertension: response to bosentan therapy","volume":"172","author":"Girgis","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"issue":"22","key":"10.1016\/j.ccm.2013.08.013_bib92","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1161\/01.CIR.102.22.2720","article-title":"Increased plasma P-selectin and decreased thrombomodulin in pulmonary arterial hypertension were improved by continuous prostacyclin therapy","volume":"102","author":"Sakamaki","year":"2000","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ccm.2013.08.013_bib93","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1161\/01.CIR.70.4.580","article-title":"Primary pulmonary hypertension: natural history and the importance of thrombosis","volume":"70","author":"Fuster","year":"1984","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ccm.2013.08.013_bib94","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1378\/chest.112.3.714","article-title":"The effect of anticoagulant therapy in primary and anorectic drug-induced pulmonary hypertension","volume":"112","author":"Frank","year":"1997","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.ccm.2013.08.013_bib95","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1056\/NEJM199207093270203","article-title":"The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension","volume":"327","author":"Rich","year":"1992","journal-title":"N\u00a0Engl J Med"},{"issue":"Suppl 3","key":"10.1016\/j.ccm.2013.08.013_bib96","doi-asserted-by":"crossref","first-page":"287S","DOI":"10.1378\/chest.126.3_suppl.287S","article-title":"Hemorrhagic complications of anticoagulant treatment: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy","volume":"126","author":"Levine","year":"2004","journal-title":"Chest"},{"issue":"Suppl 2","key":"10.1016\/j.ccm.2013.08.013_bib97","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1365-2362.2009.02122.x","article-title":"Bleeding events in pulmonary arterial hypertension","volume":"39","author":"Opitz","year":"2009","journal-title":"Eur J Clin Invest"},{"issue":"9","key":"10.1016\/j.ccm.2013.08.013_bib98","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1111\/j.1572-0241.1998.00462.x","article-title":"Gastrointestinal hemorrhage in patients with systemic sclerosis and CREST syndrome","volume":"93","author":"Duchini","year":"1998","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.ccm.2013.08.013_bib99","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3899\/jrheum.110765","article-title":"Warfarin in systemic sclerosis-associated and idiopathic pulmonary arterial hypertension. A Bayesian approach to evaluating treatment for uncommon disease","volume":"39","author":"Johnson","year":"2012","journal-title":"J\u00a0Rheumatol"},{"issue":"1","key":"10.1016\/j.ccm.2013.08.013_bib100","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.clinthera.2010.01.004","article-title":"Warfarin and bosentan interaction in a patient with pulmonary hypertension secondary to bilateral pulmonary emboli","volume":"32","author":"Spangler","year":"2010","journal-title":"Clin Ther"},{"issue":"5","key":"10.1016\/j.ccm.2013.08.013_bib101","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/MCP.0b013e328349289a","article-title":"The incidence of recurrent venous thromboembolism and chronic thromboembolic pulmonary hypertension following a first episode of pulmonary embolism","volume":"17","author":"Poli","year":"2011","journal-title":"Curr Opin Pulm Med"},{"issue":"4","key":"10.1016\/j.ccm.2013.08.013_bib102","first-page":"747","article-title":"Impairment of hypoxic pulmonary artery remodeling by heparin in mice","volume":"128","author":"Hales","year":"1983","journal-title":"Am Rev Respir Dis"},{"issue":"1","key":"10.1016\/j.ccm.2013.08.013_bib103","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1164\/ajrccm\/145.1.193","article-title":"Partial reversal of hypoxic pulmonary hypertension by heparin","volume":"145","author":"Hassoun","year":"1992","journal-title":"Am Rev Respir Dis"},{"issue":"3","key":"10.1016\/j.ccm.2013.08.013_bib104","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1164\/ajrccm\/139.3.763","article-title":"Effect of heparin and warfarin on chronic hypoxic pulmonary hypertension and vascular remodeling in the guinea pig","volume":"139","author":"Hassoun","year":"1989","journal-title":"Am Rev Respir Dis"},{"issue":"4","key":"10.1016\/j.ccm.2013.08.013_bib105","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.bbrc.2006.05.060","article-title":"Gene expression of cyclin-dependent kinase inhibitors and effect of heparin on their expression in mice with hypoxia-induced pulmonary hypertension","volume":"345","author":"Yu","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10.1016\/j.ccm.2013.08.013_bib106","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/cvr\/cvr168","article-title":"A\u00a0role for coagulation factor Xa in experimental pulmonary arterial hypertension","volume":"92","author":"Delbeck","year":"2011","journal-title":"Cardiovasc Res"},{"issue":"2","key":"10.1016\/j.ccm.2013.08.013_bib107","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1056\/NEJM198001103020201","article-title":"Oral hydralazine therapy for primary pulmonary hypertension","volume":"302","author":"Rubin","year":"1980","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.ccm.2013.08.013_bib108","first-page":"352","article-title":"Primary pulmonary hypertension: effects of nifedipine","volume":"44","author":"Camerini","year":"1980","journal-title":"Br\u00a0Heart J"},{"issue":"22","key":"10.1016\/j.ccm.2013.08.013_bib109","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1056\/NEJM198206033062203","article-title":"Deleterious effects of hydralazine in patients with pulmonary hypertension","volume":"306","author":"Packer","year":"1982","journal-title":"N\u00a0Engl J Med"},{"issue":"13","key":"10.1016\/j.ccm.2013.08.013_bib110","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1161\/CIRCULATIONAHA.104.503540","article-title":"Pulmonary arterial hypertension","volume":"114","author":"McLaughlin","year":"2006","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ccm.2013.08.013_bib111","doi-asserted-by":"crossref","first-page":"278","DOI":"10.7326\/0003-4819-148-4-200802190-00006","article-title":"Narrative review: the enigma of pulmonary arterial hypertension: new insights from genetic studies","volume":"148","author":"Newman","year":"2008","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.ccm.2013.08.013_bib112","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/0735-1097(91)90556-O","article-title":"High dose titration of calcium channel blocking agents for primary pulmonary hypertension: guidelines for short-term drug testing","volume":"18","author":"Rich","year":"1991","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"23","key":"10.1016\/j.ccm.2013.08.013_bib113","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1161\/CIRCULATIONAHA.104.488486","article-title":"Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension","volume":"111","author":"Sitbon","year":"2005","journal-title":"Circulation"},{"issue":"15","key":"10.1016\/j.ccm.2013.08.013_bib114","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1093\/eurheartj\/ehq170","article-title":"Long-term response to calcium-channel blockers in non-idiopathic pulmonary arterial hypertension","volume":"31","author":"Montani","year":"2010","journal-title":"Eur Heart J"},{"issue":"9","key":"10.1016\/j.ccm.2013.08.013_bib115","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1164\/rccm.200510-1668OC","article-title":"Pulmonary arterial hypertension in France: results from a national registry","volume":"173","author":"Humbert","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"24","key":"10.1016\/j.ccm.2013.08.013_bib116","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1016\/j.ehj.2004.09.014","article-title":"Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology","volume":"25","author":"Galie","year":"2004","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.ccm.2013.08.013_bib117","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.rmed.2009.11.010","article-title":"Adenosine for vasoreactivity testing in pulmonary hypertension: a head-to-head comparison with inhaled nitric oxide","volume":"104","author":"Oliveira","year":"2010","journal-title":"Respir Med"},{"issue":"2","key":"10.1016\/j.ccm.2013.08.013_bib118","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1378\/chest.121.2.656","article-title":"Pulmonary edema caused by inhaled nitric oxide therapy in two patients with pulmonary hypertension associated with the CREST syndrome","volume":"121","author":"Preston","year":"2002","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.ccm.2013.08.013_bib119","first-page":"1195","article-title":"Pulmonary edema during acute infusion of epoprostenol in a patient with pulmonary hypertension and limited scleroderma","volume":"26","author":"Farber","year":"1999","journal-title":"J\u00a0Rheumatol"},{"issue":"4","key":"10.1016\/j.ccm.2013.08.013_bib120","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1378\/chest.118.4.1077","article-title":"Hemodynamic effects of epoprostenol in patients with systemic sclerosis and pulmonary hypertension","volume":"118","author":"Strange","year":"2000","journal-title":"Chest"},{"issue":"7","key":"10.1016\/j.ccm.2013.08.013_bib121","doi-asserted-by":"crossref","first-page":"485","DOI":"10.7326\/0003-4819-112-7-485","article-title":"Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol). Results of a randomized trial","volume":"112","author":"Rubin","year":"1990","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.ccm.2013.08.013_bib122","doi-asserted-by":"crossref","first-page":"409","DOI":"10.7326\/0003-4819-121-6-199409150-00003","article-title":"Survival in primary pulmonary hypertension with long-term continuous intravenous prostacyclin","volume":"121","author":"Barst","year":"1994","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.ccm.2013.08.013_bib123","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1056\/NEJM199602013340504","article-title":"A\u00a0comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension","volume":"334","author":"Barst","year":"1996","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.ccm.2013.08.013_bib124","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1161\/01.CIR.76.1.135","article-title":"High-dose calcium channel-blocking therapy for primary pulmonary hypertension: evidence for long-term reduction in pulmonary arterial pressure and regression of right ventricular hypertrophy","volume":"76","author":"Rich","year":"1987","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ccm.2013.08.013_bib125","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1136\/heart.83.4.406","article-title":"Treatment with epoprostenol reverts nitric oxide non-responsiveness in patients with primary pulmonary hypertension","volume":"83","author":"Ziesche","year":"2000","journal-title":"Heart"}],"container-title":["Clinics in Chest Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523113001135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523113001135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:49:35Z","timestamp":1759452575000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272523113001135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":125,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0272523113001135"],"URL":"https:\/\/doi.org\/10.1016\/j.ccm.2013.08.013","relation":{},"ISSN":["0272-5231"],"issn-type":[{"value":"0272-5231","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Standard Nonspecific Therapies in the Management of Pulmonary Arterial Hypertension","name":"articletitle","label":"Article Title"},{"value":"Clinics in Chest Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccm.2013.08.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}